Results 31 to 40 of about 6,419 (213)
Frontiers in Psychiatry, 2022 BackgroundSchizophrenia is considered one of the major risk factors for mortality from SARS-CoV-2 infection. Early antiviral treatment is important to decrease the risk of mortality.
Chun-I Liu +6 more
doaj +1 more source
Ranolazine Toxicity Secondary to Paxlovid
Cureus, 2023 An Emergency Use Authorization (EUA) was issued by the FDA on December 22, 2021 for the investigational antiviral drug nirmatrelvir copackaged with the HIV-1 protease inhibitor ritonavir (Paxlovid - Pfizer) for outpatient treatment of mild to moderate COVID-19 in children 12 years and old that are high risk of severe disease.
Casey, Bradley +4 more
openaire +2 more sources
Drug-drug interaction with oral antivirals for the early treatment of COVID-19 [PDF]
, 2022 Non peer ...
Kovanen, Petri T. +2 more
core +2 more sources
Serotonin Syndrome Precipitated by Paxlovid Initiation
Cureus, 2023 A female in her early 40s taking buspirone, quetiapine, and daily kratom presented to the emergency department two days after starting a course of Paxlovid for a mild COVID-19 infection with diffuse tremors, ocular clonus, diaphoresis, and confusion consistent with serotonin syndrome (SS).
Nasser, Nicholas G +3 more
openaire +2 more sources
Real‐world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study [PDF]
Signal Transduction and Targeted TherapyGuanyue Su, Zhigang Ren
exaly +2 more sources
Journal of Medical Case Reports, 2023 Background Transplant recipients are at high risk of coronavirus disease 2019, and a timely supply of antivirals should be prioritized for those patients.
Wei Luo +4 more
doaj +1 more source
The Use of Paxlovid Amongst the Elderly & Reduced Hospital Stays [PDF]
, 2023 Coronaviruses are a large family of viruses infecting many species and cause a variety of illnesses. COVID-19 is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- CoV-2).
Ames, Kate +3 more
core +1 more source
Absolute Risk Reductions in COVID-19 Antiviral Medication Clinical Trials
Pharmacoepidemiology, 2023 COVID-19 antiviral medications approved or authorized for emergency use by the U.S. Food and Drug Administration are reported to have high efficacy in preventing severe illness, hospitalizations, and deaths.
Ronald B. Brown
doaj +1 more source
A Rare Case of Paxlovid-Induced Pancreatitis
Cureus, 2023 Acute pancreatitis can result secondary to an inflammatory cascade due to an insult to the pancreatic parenchyma, whether it be from infections, medications, etc. We present a case of a 37-year-old male with acute pancreatitis after being started on Paxlovid, a combination drug containing Nirmatrelvir and Ritonavir, for COVID-19 treatment.
Zaidi, Syed Muhammad Hussain +7 more
openaire +2 more sources
Frontiers in Pediatrics, 2023 ObjectiveTo summarize the clinical characteristics of children with hematological malignancies co-infected with novel coronavirus and explore the safety and effectiveness of Paxlovid treatment.MethodsFrom December 10, 2022, to January 20, 2023, the ...
Yixian Li +8 more
doaj +1 more source